LifeStance Health Group, Inc. (LFST) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $6.51. It has a SharesGrow Score of 59/100, indicating a above average investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of LFST = $346.59 (+5224% from the current price, the stock appears undervalued). Analyst consensus target is LFST = $9 (+42.9% upside).
Valuation: LFST trades at a trailing Price-to-Earnings (P/E) of 259.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.72.
Financials: revenue is $1.4B, +18.4%/yr average growth. Net income is $10M, growing at +66.5%/yr. Net profit margin is 0.7% (thin). Gross margin is 28.5% (+0.9 pp trend).
Balance sheet: total debt is $194M against $1.5B equity (Debt-to-Equity (D/E) ratio 0.13, conservative). Current ratio is 1.65 (strong liquidity). Debt-to-assets is 8.8%. Total assets: $2.2B.
Analyst outlook: 10 / 11 analysts rate LFST as buy (91%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 51/100 (Partial), Growth 90/100 (Pass), Past 25/100 (Fail), Health 67/100 (Partial), Moat 49/100 (Partial), Future 100/100 (Pass), Income 30/100 (Fail).
